Back to Search
WARREN ROSE, M.D.
M.D.
Surgery Physician
NPI: 1538148218IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryGENERAL SURGERY
Education
CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY
Class of 1986
Research & Publications (20)
Acute pancreatitis as the initial presentation in pediatric systemic lupus erythematosus.
PMID 19475344·Indian J Pediatr·2009
5-case
Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model.
PMID 19015334·Antimicrob Agents Chemother·2009
8-other
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
PMID 19109338·J Antimicrob Chemother·2009
8-other
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.
PMID 18591272·Antimicrob Agents Chemother·2008
8-other
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model.
PMID 18263568·J Antimicrob Chemother·2008
8-other
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
PMID 17999971·Antimicrob Agents Chemother·2008
8-other
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.
PMID 17540670·J Antimicrob Chemother·2007
7-preclinical
Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
PMID 17434881·J Antimicrob Chemother·2007
8-other
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
PMID 16228206·Cancer Chemother Pharmacol·2006
7-preclinical
Tigecycline: first of a new class of antimicrobial agents.
PMID 16863487·Pharmacotherapy·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 SOUTH ST STE 108
SOUTHBRIDGE, MA 01550 - Phone
- (508) 764-6966
Quick Facts
- NPI
- 1538148218
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile